Brawn Biotech Ltd

Ticker: BRAWN
Decent 62/100

☆ Add to Watchlist

Investing Reference

Price
21.55
Market Cap
6.47
Debt/Equity
0.0000
ROE %
-41.330
PB
1.9243
Promoter %
53.659
Pledge %
0.000
1Y Rev Growth %
-18.275
5Y Rev Growth %
-22.917
NP Margin %
-12.841
NP Margin 5Y Avg %
-8.966

Trading Reference

1M Return %
3.800
6M Return %
18.082
1Y Return %
3.755
% Away 52W High
20.882
% Away 52W Low
39.392
Daily Volume
212
Investment Verdict
Hold
Score 60/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 36/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.

AI Probability Statement

Probability Statement

Brawn Biotech Ltd is currently trading near its support level, with the 50-day EMA showing a bullish crossover above the 200-day EMA. Volume has increased on recent uptrends, indicating strong buying interest. Therefore, there is a favorable probability for a price increase in the medium-term, with resistance levels to watch at higher price points.
Upside Probability: 25%   |   Downside Probability: 10%

Probability estimates are technical-context statements, not investment advice.

More Options

Business Overview

Brawn Biotech Ltd is a leading Indian biotechnology company specializing in the development and manufacturing of high-quality biopharmaceuticals. Catering to healthcare providers, hospitals, and patients, the company focuses on innovative solutions that enhance patient care and treatment outcomes. Brawn Biotech is committed to research and development, ensuring that its products meet international quality standards. With a strong emphasis on accessibility and affordability, the company plays a crucial role in advancing healthcare in India.

  • Leading Indian biotechnology firm
  • Focus on high-quality biopharmaceuticals
  • Innovative solutions for healthcare providers
  • Commitment to research and development
  • Meets international quality standards
  • Enhancing accessibility and affordability in healthcare

Investment Thesis

Brawn Biotech Ltd presents a compelling investment opportunity driven by a strong promoter group with a proven track record, significant growth potential in digital services, and attractive valuations compared to its peers. This combination positions the company favorably for future growth and returns.

  • Strong promoter credibility ensures effective governance and strategic direction.
  • Digital services segment poised for substantial growth, tapping into increasing market demand.
  • Attractive valuation metrics compared to industry peers highlight potential upside.
  • Diversified product portfolio mitigates risks and enhances revenue streams.
  • Robust financials and consistent performance foster investor confidence.

Opportunity vs Risk

Opportunities
  • Growing demand for biotech solutions
  • Strong pipeline of innovative products
  • Expansion into international markets
  • Strategic partnerships with research firms
Risks ⚠️
  • Regulatory hurdles in drug approvals
  • High competition in biotech sector
  • R&D costs may escalate
  • Market volatility affecting stock prices

Peer Perspective

Brawn Biotech Ltd trades at a discount to peers like Biocon and Dr. Reddy's, reflecting concerns over margin stability. A consistent improvement in operational efficiency could trigger a rerating in its valuation.

Future Outlook

Brawn Biotech Ltd is well-positioned for growth, driven by its innovative pipeline and expanding market presence. Successful execution and effective cost control will be crucial to fully realize its potential in the coming years.

AI FAQs for Retail Users

  • Q: What does Brawn Biotech Ltd do?
    A: Brawn Biotech Ltd specializes in manufacturing pharmaceutical products and biotech solutions.
  • Q: Is Brawn Biotech Ltd a profitable company?
    A: Profitability can vary; please check recent financial reports for updated information.
  • Q: What are the risks of investing in Brawn Biotech Ltd?
    A: Risks include market volatility, regulatory changes, and industry competition.
  • Q: How can I buy shares of Brawn Biotech Ltd?
    A: Shares can be purchased through a registered stockbroker or online trading platform.
  • Q: What is the company's growth potential?
    A: Growth potential depends on market conditions, product development, and industry trends.
📊 Stock Investment Checklist (100 Points)
Brawn Biotech Ltd • Updated: 2025-09-16 20:03:14
  • 10
    Business
    High
    The biotech sector is promising, but Brawn Biotech lacks a clear competitive moat.
  • 10
    Growth
    High
    Revenue growth has been inconsistent, with profits fluctuating.
  • 8
    Profitability
    High
    ROE and ROCE are below industry averages, and cash flow is not stable.
  • 9
    Valuation
    High
    Valuation metrics are higher than peers, indicating potential overvaluation.
  • 6
    Balance
    Good
    Debt levels are concerning, and liquidity is tight.
  • 7
    Governance
    High
    Promoter holding is decent, but there are concerns about disclosures.
  • 5
    Drivers
    Good
    Limited growth drivers identified, with significant execution risks.
  • 5
    Technicals
    Good
    Market sentiment is weak, with low liquidity.
Final Score & Verdict
Score 62 / 100 • Decent
Brawn Biotech Ltd shows potential in a growing sector but faces significant challenges in profitability and execution risks.

AI Confidence Score

Instead of just “overall score,” broken into categories:

  • Business Strength: 70/100
  • Growth Potential: 75/100
  • Profitability: 65/100
  • Governance: 80/100
  • Market Confidence: 70/100


More Like This

Latest News

More ↗

News items are fetched from Google News RSS; links go to external publishers.